Form 4: Alkermes VP Finance Exercises RSUs, Sells Shares

Alkermes plc's VP of Finance, Samuel Joseph Parisi, reported the vesting and exercise of restricted stock units and a subsequent sale of shares for tax purposes.

Summary

• Samuel Joseph Parisi, VP, Finance (Interim PAO) of Alkermes plc, reported transactions on February 23, 2026.
• Acquired 2,283 ordinary shares through the vesting of a Restricted Stock Unit (RSU) award.
• Disposed of 672 ordinary shares at a price of $32.19 per share, likely to cover tax obligations related to the RSU vesting.
• Following these transactions, Parisi directly beneficially owns 12,668 ordinary shares.
• An additional 2,284 restricted stock units remain unvested.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine executive compensation and a continued alignment of executive interests with shareholders, despite a small tax-related share sale.

Positives

• The vesting of restricted stock units indicates continued long-term incentive compensation for a key executive.
• The executive's continued beneficial ownership of 12,668 ordinary shares aligns his interests with shareholders.

Negatives

• The sale of 672 shares, while common for tax purposes, represents a reduction in direct shareholding.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting schedule of the remaining restricted stock units.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for public company insiders, reflecting changes in their beneficial ownership. These transactions, particularly those involving RSU vesting and subsequent tax-related sales, are common in executive compensation structures within the pharmaceutical and biotechnology industry, such as Alkermes plc.

Stakeholder Impact

• Shareholders: The executive's continued ownership aligns interests, while the tax-related sale is a minor, routine event.
• Employees: Reflects standard executive compensation practices.

Next Steps

• Future vesting of the remaining 2,284 restricted stock units in equal annual installments.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of restricted stock units and a subsequent sale of shares for tax purposes. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The executive's continued significant share ownership suggests ongoing alignment with shareholder interests. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

Alkermes, ALKS, Form 4, Insider Trading, Restricted Stock Units, RSU, Executive Compensation, Share Sale, Samuel Joseph Parisi